Smith Brendan Insider Trades

Insider Trading History

Track insider trading activity for Smith Brendan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $256k 5,072 shares
Last Trade
Feb 21, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$67.2k 1,392 shares
$48.26
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $579k 11,475 shares
Last Trade
Feb 18, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$195k 3,825 shares
$50.89
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $326k 6,464 shares
Last Trade
Feb 18, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$195k 3,825 shares
$50.89
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $133k 2,639 shares
Last Trade
Oct 17, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$61.9k 1,111 shares
$55.76
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $568k 11,250 shares
Last Trade
Oct 14, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$406k 7,500 shares
$54.07
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $706k 14,000 shares
Last Trade
Oct 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$863k 14,000 shares
$61.65
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $505k 10,000 shares
Last Trade
Aug 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$759k 10,000 shares
$75.85
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $1.51M 30,000 shares
Last Trade
Feb 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.64M 45,300 shares
$58.29
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $4.54M 90,000 shares
Last Trade
Oct 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4M 105,000 shares
$98.70
$50.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up